June 14, 2026
Every day, AI-powered medical devices make decisions that affect patient safety. An algorithm recommends a diagnosis. An insulin pump adjusts dosage. A radiology system flags a suspicious finding. These decisions happen automatically, at machine speed, without human intervention.
Regulators require that these decisions be provably safe and effective. The FDA demands predetermined change control plans for AI/ML‑enabled devices. IEC 62304 requires traceability. ISO 14971 mandates risk management.
But here is the problem: most medical AI systems are probabilistic. They learn. They adapt. They change. The same patient data today might produce a different recommendation tomorrow.
That is not provably safe. That is not auditable. That is a regulatory violation waiting to surface.
The Gap in Medical Device Audit
Traditional medical device logging captures outputs. It records what the device did—the dosage delivered, the finding flagged, the recommendation made.
What it does not capture is the decision itself. Why did the algorithm choose that threshold? What signals led to that classification? Would the same inputs produce the same output next week?
The FDA is starting to ask these questions. Predetermined change control plans require manufacturers to prove that algorithm updates are safe and effective. That proof requires a record of how decisions were made before and after the change.
Without a deterministic audit trail, manufacturers cannot answer the regulator's question.
What Deterministic Audit Provides
A deterministic decision audit is different. It captures the inputs that led to a decision, applies fixed rules, and produces an output that is identical every time.
For medical devices, this means:
- Every clinical decision is logged with its full context
- The rationale is human‑readable and regulator‑ready
- The same patient data always produces the same output
- Auditors can replay any past decision and verify consistency
This is not evidence collection. This is proof.
How It Works
Consider an AI‑powered diagnostic system.
Input:
{
"scenario_summary": "Chest X‑ray classification",
"observed_signals": [
"nodule detected",
"confidence 0.87",
"prior scan available"
],
"known_context": [
"protocol version 2.4",
"FDA approved indication",
"radiologist override available"
]
}
Output:
{
"decision_posture": "proceed",
"confidence": 87,
"compliance_references": [
"FDA 21 CFR 820.30 - Design Controls",
"IEC 62304 - Software Development Lifecycle",
"ISO 14971 - Risk Management",
"SOC2 CC6.1 - Access Control",
"ISO27001 A.9.2.1 - User Access"
],
"decision_rationale": "Nodule detected with high confidence. Protocol version 2.4 approved for this indication. Prior scan available for comparison. Radiologist override available. Proceed with classification.",
"clarifying_question": null
}
The regulator does not need to trust the system. The regulator can test it. Run the same inputs through the same API. Get the same output.
That is not trust. That is verification.
Why This Matters Now
The regulatory window is closing. The FDA's predetermined change control guidance is active. IEC 62304 requires traceability. ISO 14971 demands risk management.
Manufacturers that cannot explain their AI‑driven clinical decisions will face regulatory delays, rejected submissions, or worse. Manufacturers that can provide deterministic audit trails will move freely.
The technology exists. The framework is mapped. The API is live.
What Comes Next
The same deterministic engine that serves SOC2 compliance now serves medical devices. One API call. Multiple frameworks. Full audit trail.
If your medical AI is making clinical decisions that regulators might ask about, you have a choice. Explain after the fact with reconstructed logs. Or prove before the audit with deterministic proof.
Patient safety depends on correct decisions. Regulators depend on proof of correctness.
The API is live. The question is whether you will use it.
Founder & CEO, Decision Security Layer
https://seais-decision-core.onrender.com
Contact: decseclayer@gmail.com
